Table 3.
Association of White Blood Cell Trait Variants with Immune-Mediated Diseases and Clinical Phenotypes in Previous Genome-wide Association Studies
| Trait (Population) | dbSNP ID | Chr | Pos | Alt/Ref | Gene | Phenotype | Sample Size | p Valuea |
|---|---|---|---|---|---|---|---|---|
| WBC (EA) | rs1260328 | 2 | 27,730,940 | C/T | GCKR | inflammatory bowel disease | 96,486 | 1.27 × 10−4 |
| LYM (EA) | rs2229094b | 6 | 31,540,556 | C/T | LTA | Crohn disease | 69,268 | 7.81 × 10−7 |
| LYM (EA) | rs2229094b | 6 | 31,540,556 | C/T | LTA | systemic lupus erythematosus | 23,209 | 3.09 × 10−7 |
| LYM (EA) | rs2229094b | 6 | 31,540,556 | C/T | LTA | primary biliary cirrhosis | 21,216 | 1.31 × 10−5 |
| WBC (All) | rs185819 | 6 | 32,050,067 | C/T | TNXB | multiple sclerosisc | 22,850 | 2.16 × 10−6 |
| WBC (All) | rs185819 | 6 | 32,050,067 | C/T | TNXB | type 1 diabetes | 33,394 | 3.29 × 10−9 |
| WBC (All) | rs185819 | 6 | 32,050,067 | C/T | TNXB | ulcerative colitis | 72,647 | 2.91 × 10−6 |
| WBC (All) | rs185819 | 6 | 32,050,067 | C/T | TNXB | systemic lupus erythematosusc | 23,209 | 2.32 × 10−37 |
| WBC (All) | rs185819 | 6 | 32,050,067 | C/T | TNXB | rheumatoid arthritis | 103,558 | 3.90 × 10−53 |
| MON (All) | rs4917014 | 7 | 50,305,863 | G/T | C7orf72-IKZF1 | systemic lupus erythematosus | 32,444 | 8.10 × 10−5 |
| MON (All) | rs4917014 | 7 | 50,305,863 | G/T | C7orf72-IKZF1 | inflammatory bowel disease | 96,486 | 4.59 × 10−5 |
| MON (All) | rs4917014 | 7 | 50,305,863 | G/T | C7orf72-IKZF1 | Crohn disease | 69,268 | 1.49 × 10−4 |
| MON (All) | rs4917014 | 7 | 50,305,863 | G/T | C7orf72-IKZF1 | Stevens-Johnson syndrome/toxic epidermal necrolysis | 1,129 | 8.00 × 10−11 |
| MON (All) | rs4917014 | 7 | 50,305,863 | G/T | C7orf72-IKZF1 | selective immunoglobulin a deficiency | 2,748 | 2.80 × 10−23 |
| LYM (EA) | rs4763879 | 12 | 9,910,164 | A/G | CD69 | type 1 diabetes | 38,522 | 1.90 × 10−11 |
| LYM (EA) | rs4763879 | 12 | 9,910,164 | A/G | CD69 | multiple sclerosis | 38,135 | 2.18 × 10−5 |
| LYM (EA) | rs4763879 | 12 | 9,910,164 | A/G | CD69 | selective immunoglobulin A deficiency | 2,748 | 1.90 × 10−11 |
| MON (EA) | rs11642873 | 16 | 85,991,705 | C/A | IRF8-LINC01082 | systemic lupus erythematosus | 23,209 | 3.56 × 10−10 |
| MON (EA) | rs11642873 | 16 | 85,991,705 | C/A | IRF8-LINC01082 | systemic sclerosis | 14,853 | 2.30 × 10−12 |
| WBC (EA); MON (All) | rs1292053 | 17 | 57,963,537 | G/A | TUBD1 | multiple sclerosis | 38,135 | 7.47 × 10−6 |
| WBC (EA); MON (All) | rs1292053 | 17 | 57,963,537 | G/A | TUBD1 | Crohn disease | 96,486 | 8.53 × 10−6 |
| WBC (EA); MON (All) | rs1292053 | 17 | 57,963,537 | G/A | TUBD1 | inflammatory bowel disease | 96,486 | 9.61 × 10−5 |
| WBC (EA); NEU (EA) | rs4760 | 19 | 44,153,100 | G/A | CD87 (PLAUR) | ulcerative colitis | 72,647 | 1.51 × 10−4 |
| WBC (EA) | rs3865444 | 19 | 51,727,962 | A/C | CD33 | Alzheimer disease | 59,716 | 1.60 × 10−9 |
| BAS (EA) | rs2295764 | 20 | 31,025,163 | G/A | ASXL1 | somatic mutations in MDS, CML, and ICUS | – | – |
| WBC (All) | rs2836878 | 21 | 40,465,534 | A/G | ETS2-PSMG1 | ankylosing spondylitis | 9,609 | 4.90 × 10−12 |
| WBC (All) | rs2836878 | 21 | 40,465,534 | A/G | ETS2-PSMG1 | Crohn disease | 69,268 | 2.43 × 10−6 |
| WBC (All) | rs2836878 | 21 | 40,465,534 | A/G | ETS2-PSMG1 | ulcerative colitis | 72,647 | 2.05 × 10−20 |
| WBC (All) | rs2836878 | 21 | 40,465,534 | A/G | ETS2-PSMG1 | inflammatory bowel disease | 96,486 | 3.70 × 10−22 |
| WBC (All) | rs2836878 | 21 | 40,465,534 | A/G | ETS2-PSMG1 | selective immunoglobulin A deficiency | 2,748 | 1.40 × 10−8 |
Abbreviations: Chr, chromosome; Pos, basepair position; Alt, effect allele; Ref, reference allele; CML, chronic myelogenous leukemia; ICUS, Idiopathic cytopenia of undetermined significance; MDS, myelodysplastic syndrome, WBC, white blood cell; NEU, neutrophil; MON, monocyte; LYM, lymphocyte; BAS, basophil.
Significant results are shown after correcting for multiple testing of 16 variants and 15 diseases (p < 2.08 × 10−4). When multiple studies report the same variant-trait associations, results from the largest sample size are presented here.
LD r2 between rs2229094 and rs1799964 is 0.75.
Phenome-wide association results. Permutation p value for association with multiple sclerosis was 0.0122.